Along with the fine, the long-running investigation has concluded that Teva used a "web" of patents to illegally block lower-cost generic versions of Copaxone (glatiramer acetate), whose last ...

Regardless of sociodemographic or clinical characteristics, children with food allergy face a significant psychosocial burden ...

Biohaven, acquired by Pfizer in 2022, allegedly took doctors to high-end restaurants and paid speaker honoraria for ...

At the same time, it was facing dwindling sales of its own MS blockbuster Copaxone (glatiramer acetate), which had been driving the business for years. Five years on, and Teva is still facing ...